EZH2 and mantle cell lymphoma: However, such EZH2 activating mutations, have not been reported or identified in the whole exome sequencing data from MCL patient samples (18, 19), as a result, the role of PRC2 and wt-EZH2 in MCL has been historically considered to be limited.